A, K., MJ, L., SN, B., B, B., F, O., & AL, M. (2022). Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination. Clinical and experimental dermatology, 47(1), 161. https://doi.org/10.1111/ced.14858
Chicago Style (17th ed.) CitationA, Kreuter, Licciardi-Fernandez MJ, Burmann SN, Burkert B, Oellig F, and Michalowitz AL. "Induction and Exacerbation of Subacute Cutaneous Lupus Erythematosus Following MRNA-based or Adenoviral Vector-based SARS-CoV-2 Vaccination." Clinical and Experimental Dermatology 47, no. 1 (2022): 161. https://doi.org/10.1111/ced.14858.
MLA (9th ed.) CitationA, Kreuter, et al. "Induction and Exacerbation of Subacute Cutaneous Lupus Erythematosus Following MRNA-based or Adenoviral Vector-based SARS-CoV-2 Vaccination." Clinical and Experimental Dermatology, vol. 47, no. 1, 2022, p. 161, https://doi.org/10.1111/ced.14858.